Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous white-cell serum therapy versus platelet-rich plasma for patellar tendinopathy
2017-002129-39Phase 2Completed
- Sponsor
- XCELL Medical Solutions
- Start
- Aug 2017
- Countries
- 1
01
Overview
A Phase 2 trial of platelet-rich plasma in Patellar Tendinitis (PT), sponsored by XCELL Medical Solutions. Started Aug 2017; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
Patellar Tendinitis (PT)
Beyond the preview
Go deeper on 2017-002129-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002129-39.